Molecular Mechanisms of Preeclampsia

Overview

Journal Microvasc Res

Specialty Cardiology & Vascular Diseases

Date 2007 Jun 8

PMID 17553534

Citations 104

Authors

Walter P Mutter

S Ananth Karumanchi

Affiliations

Soon will be listed here.

Abstract

Preeclampsia is a major cause of maternal, fetal and neonatal mortality worldwide. The mechanisms that initiate preeclampsia in humans have been elusive, but some parts of the puzzle have begun to come together. A key discovery in the field was the realization that its major phenotypes, such as hypertension and proteinuria, are due to excess circulating soluble fms-like tyrosine kinase-1 (sFlt-1, also referred to as sVEGFR-1). sFlt-1 is an endogenous anti-angiogenic protein that is made by the placenta and acts by neutralizing the pro-angiogenic proteins vascular endothelial growth factor (VEGF) and placental growth factor (PlGF). More recently, soluble endoglin, another circulating anti-angiogenic protein was found to synergize with sFlt-1 and contribute to the pathogenesis of preeclampsia. Abnormalities in these circulating angiogenic proteins are not only present during clinical preeclampsia, but also antedate clinical symptoms by several weeks. This review will summarize our current understanding of the molecular mechanism of preeclampsia, with an emphasis on the recently characterized circulating anti-angiogenic proteins.

Citing Articles

The Association Between Maternal Preeclampsia and Risk for Offspring Infectious Diseases-A Sibling Matched Analysis.

Marciano D, Sheiner E, Sergienko R, Wainstock T Am J Reprod Immunol. 2025; 93(1):e70041.

PMID: 39792568 PMC: 11722688. DOI: 10.1111/aji.70041.

Economic analysis of the use of the Flt-1/PlGF preeclampsia ratio compared to the standard of care in Uruguay.

Guinazu G, Tomasso G, Vitureira G, Rey G, Fiol V, Sosa L Rev Colomb Obstet Ginecol. 2024; 75(3.

PMID: 39530873 PMC: 11655075. DOI: 10.18597/rcog.4148.

Both endothelial mineralocorticoid receptor expression and hyperleptinemia are required for clinical characteristics of placental ischemia in mice.

Moronge D, Ayulo V, Elgazzaz M, Mellott E, Ogbi S, Faulkner J Am J Physiol Heart Circ Physiol. 2024; 327(1):H118-H130.

PMID: 38758130 PMC: 11380964. DOI: 10.1152/ajpheart.00188.2024.

An exploratory study on the association of multiple metals in serum with preeclampsia.

He J, Pu Y, Du Y, Liu H, Wang X, He S Front Public Health. 2024; 12:1336188.

PMID: 38504684 PMC: 10948457. DOI: 10.3389/fpubh.2024.1336188.

Unraveling the Predictive Power: Placenta Growth Factor and Pregnancy-Associated Plasma Protein A in Pre-eclampsia.

Singh Thakur A, Tayade S, Patel D, Gupta A, Batra N Cureus. 2024; 16(1):e52752.

PMID: 38389635 PMC: 10881904. DOI: 10.7759/cureus.52752.

References

Ballermann B . Glomerular endothelial cell differentiation. Kidney Int. 2005; 67(5):1668-71. DOI: 10.1111/j.1523-1755.2005.00260.x. View

Shibata E, Rajakumar A, Powers R, Larkin R, Gilmour C, Bodnar L . Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab. 2005; 90(8):4895-903. DOI: 10.1210/jc.2004-1955. View

Ray J, Vermeulen M, Schull M, Redelmeier D . Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005; 366(9499):1797-803. DOI: 10.1016/S0140-6736(05)67726-4. View

Maharaj A, Saint-Geniez M, Maldonado A, DAmore P . Vascular endothelial growth factor localization in the adult. Am J Pathol. 2006; 168(2):639-48. PMC: 1606504. DOI: 10.2353/ajpath.2006.050834. View

Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim Y . Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006; 12(6):642-9. DOI: 10.1038/nm1429. View

Clark B, Halvorson L, Sachs B, EPSTEIN F . Plasma endothelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment. Am J Obstet Gynecol. 1992; 166(3):962-8. DOI: 10.1016/0002-9378(92)91372-h. View

Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, Massague J . Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem. 1992; 267(27):19027-30. View

Shweiki D, Itin A, Soffer D, Keshet E . Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992; 359(6398):843-5. DOI: 10.1038/359843a0. View

McCarthy A, Woolfson R, Raju S, Poston L . Abnormal endothelial cell function of resistance arteries from women with preeclampsia. Am J Obstet Gynecol. 1993; 168(4):1323-30. DOI: 10.1016/0002-9378(93)90389-z. View

10.

Hsu C, Iriye B, Johnson T, Witter F, Hong S, Chan D . Elevated circulating thrombomodulin in severe preeclampsia. Am J Obstet Gynecol. 1993; 169(1):148-9. DOI: 10.1016/0002-9378(93)90151-8. View

11.

Kendall R, Thomas K . Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci U S A. 1993; 90(22):10705-9. PMC: 47846. DOI: 10.1073/pnas.90.22.10705. View

12.

CROSS J, Werb Z, Fisher S . Implantation and the placenta: key pieces of the development puzzle. Science. 1994; 266(5190):1508-18. DOI: 10.1126/science.7985020. View

13.

FRIEDMAN S, Schiff E, Emeis J, Dekker G, Sibai B . Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol. 1995; 172(1 Pt 1):202-3. DOI: 10.1016/0002-9378(95)90113-2. View

14.

Baker P, Davidge S, Barankiewicz J, Roberts J . Plasma of preeclamptic women stimulates and then inhibits endothelial prostacyclin. Hypertension. 1996; 27(1):56-61. DOI: 10.1161/01.hyp.27.1.56. View

15.

Ahmed A, Li X, Dunk C, Whittle M, Rushton D, Rollason T . Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors. 1995; 12(3):235-43. DOI: 10.3109/08977199509036883. View

16.

Hubel C, McLaughlin M, Evans R, Hauth B, Sims C, Roberts J . Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol. 1996; 174(3):975-82. DOI: 10.1016/s0002-9378(96)70336-8. View

17.

Kolben M, Lopens A, Blaser J, Huber A, Frank M, Wilhelm O . [Measuring the concentration of various plasma and placenta extract proteolytic and vascular factors in pregnant patients with HELLP syndrome, pre-/eclampsia and highly pathologic Doppler flow values]. Gynakol Geburtshilfliche Rundsch. 1995; 35 Suppl 1:126-31. View

18.

Forsythe J, Jiang B, Iyer N, Agani F, Leung S, Koos R . Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996; 16(9):4604-13. PMC: 231459. DOI: 10.1128/MCB.16.9.4604. View

19.

Kendall R, Wang G, Thomas K . Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun. 1996; 226(2):324-8. DOI: 10.1006/bbrc.1996.1355. View

20.

Roberts J, Cooper D . Pathogenesis and genetics of pre-eclampsia. Lancet. 2001; 357(9249):53-6. DOI: 10.1016/s0140-6736(00)03577-7. View